DOACs and "newer" hemophilia therapies in COVID-19: Reply

Affiliations

• ¹ Department of Haematology, Manchester University Hospitals, Manchester, UK.
• ² Tongji Hospital, Huazhong University of Science and Technology, Wuhan, China.
• ³ Department of Acute and Critical Care Medicine, Sapporo Higashi Tokushukai Hospital, Sapporo, Japan.
• ⁴ Department of Transfusion Medicine and Hematology, Hospital Papa Giovanni, XXIII, Bergamo, Italy.
• ⁵ University of Milan Bicocca, Bergamo, Italy.
• ⁶ ASST Santi Paolo e Carlo, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Milan, Italy.
• ⁷ Department of Medicine and Cardio-metabolic Programme-NIHR UCLH/UCL BRC, University College London Hospitals NHS Foundation Trust, London, UK.
• ⁸ Director of Programs and Education, International Society on Thrombosis and Haemostasis, Carrboro, North Carolina.
• ⁹ Department of Emergency and Disaster Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.